NASDAQ:APVO | Key Financial Ratios | Aptevo Therapeutics Inc.

Complete source-backed ratio history.

Available history
2015-12-31 to 2026-06-30
Data captured

Historical Key Financial Ratios

DateCurrent ratioDebt/equityROAROE
2026-06-302.08-181.89%-437.15%
2026-03-313.36-131.93%-226.11%
2025-12-313.82-95.49%-149.40%
2025-09-304.03-98.06%-152.21%
2025-06-302.27-153.77%-368.26%
2025-03-310.67-284.15%1609.23%
2024-12-311.72-154.77%-507.47%
2024-09-301.7-156.62%-536.67%
2024-06-301.77-167.24%-559.13%
2024-03-311.92-153.26%-442.72%
2023-12-312.64-70.09%-142.48%
2023-09-303.09-59.53%-109.74%
2023-06-303.28-60.39%-107.43%
2023-03-314.9152.90%79.54%
2022-12-313.150.1923.46%44.66%
2022-09-303.160.2520.18%40.58%
2022-06-304.4818.16%30.56%
2022-03-311.75-63.96%491.13%
2021-12-311.5112.64-50.28%-2340.21%
2021-09-301.82-45.68%-400.96%
2021-06-302.13-40.62%-209.15%
2021-03-312.14-40.58%-265.64%
2020-12-313.252-33.15%-106.97%
2020-09-304.13-50.43%-856.99%
2020-06-301.5-102.67%-219.70%
2020-03-312.12-101.14%-168.51%
2019-12-310.78-75.73%-341.56%
2019-09-300.99-76.63%-235.01%
2019-06-302.63-78.70%-198.63%
2019-03-313.15-64.14%-132.51%
2018-12-312.76-79.54%-176.57%
2018-09-303.91-62.48%-112.09%
2018-06-303.660.351.23%1.98%
2018-03-314.470.283.06%4.48%
2017-12-315.140.235.96%8.50%
2017-09-307.761.36%1.98%
2017-06-305.65-124.09%-209.69%
2017-03-315.35-111.94%-178.04%
2016-12-313.65-122.38%-222.31%
2016-09-305.21-114.65%-180.97%
2016-06-30-42.19%-57.93%
2015-12-311.76

Annual Key Financial Ratios

DateCurrent ratioDebt/equityROAROE
2025-12-313.82-95.49%-149.40%
2024-12-311.72-154.77%-507.47%
2023-12-312.64-70.09%-142.47%
2022-12-313.150.1923.46%44.66%
2021-12-311.5112.64-50.28%-2340.21%
2020-12-313.252-33.15%-106.97%
2019-12-310.78-75.73%-341.56%
2018-12-312.76-79.55%-176.57%
2017-12-315.140.235.96%8.50%
2016-12-313.65-122.38%-222.31%
2015-12-311.76-46.43%-66.94%